CNOT8 Human

CCR4-NOT Transcription Complex, Subunit 8 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Identity and Structure

  • Gene location: Chromosome 5 (5q34) .

  • Protein length: 292 amino acids .

  • Aliases: CALIF, POP2, CAF1, Caf1b .

  • Domains: Contains a DEDDh exonuclease domain critical for deadenylase activity .

Table 1: Key Identifiers

PropertyDetailSource
Gene ID (HGNC)HGNC:9207
UniProt IDQ9UFF9
Protein familyCAF1 family

Functional Roles

CNOT8 is a core component of the CCR4-NOT complex, which executes:

  1. mRNA deadenylation: Shortens poly(A) tails, initiating mRNA decay .

  2. Translational repression: Mediates miRNA-driven gene silencing .

  3. Transcriptional regulation: Modulates RNA polymerase II activity .

Key enzymatic activity:

  • 3'→5' poly(A)-specific exoribonuclease activity .

  • Partially redundant with CNOT7, its paralog (76% amino acid identity) .

Protein Interactions

CNOT8 interacts with multiple partners to coordinate mRNA turnover and signaling:

Table 2: Key Interaction Partners

PartnerRole in Complex/FunctionInteraction Evidence
CNOT1Scaffold for CCR4-NOT assembly
CNOT3Stabilizes complex structure
BTG2Enhances anti-proliferative activity
PATL1Links deadenylation to mRNA decapping
CNOT6/6LTransient association for deadenylation

Cell Cycle Regulation

  • Depletion of CNOT8 or CNOT7 causes G1-phase arrest and reduced S-phase entry .

  • Synergistic knockdown of CNOT7/CNOT8 upregulates cell cycle inhibitors (e.g., CCNG2, EGR1) and destabilizes proliferation .

DNA Damage Response (DDR)

  • CNOT8 depletion sensitizes cells to ionizing radiation (IR):

    • Reduces phosphorylation of DDR kinases (ATM, CHK2) .

    • Increases RAD51 foci formation, suggesting impaired homologous recombination repair .

Developmental Regulation

  • Zebrafish cnot8 mutants exhibit increased dopaminergic neurons due to elevated FGF signaling mRNA stability .

Gene Expression Profiling

  • Combined CNOT7/CNOT8 knockdown in MCF7 cells deregulates 255 genes (164 upregulated, 91 downregulated) .

  • Stabilized mRNAs (e.g., PMP22, CCNG2) show prolonged half-lives in knockdown models .

Table 3: Functional Redundancy Between CNOT7 and CNOT8

FeatureCNOT7CNOT8
Knockdown phenotypeG1 arrest, reduced proliferationSimilar to CNOT7
mRNA targetsOverlap with CNOT8 (~80%)Unique targets in DDR pathways
Developmental roleSpermatogenesis, bone densityNeurodevelopment

Enzymatic Redundancy

  • CNOT8 compensates for CNOT7 loss in mRNA deadenylation but exhibits unique roles in metabolic regulation .

Clinical and Therapeutic Implications

  • Cancer: CNOT8 supports cancer cell viability; its depletion reduces ATP levels and proliferation in HeLa cells .

  • Neurological disorders: Dysregulation linked to aberrant dopaminergic neuron development .

  • Therapeutic targeting: Potential for inhibiting CCR4-NOT complex in hyperproliferative diseases .

Technical Insights

  • Recombinant CNOT8: Available with >85% purity for in vitro studies (e.g., SDS-PAGE, mass spectrometry) .

  • Antibodies: Commercial tools enable detection in nuclear/cytoplasmic compartments .

Unresolved Questions

  1. How do CNOT7/CNOT8 achieve substrate specificity despite redundancy?

  2. Role of CNOT8 in non-canonical pathways (e.g., BMP signaling)?

  3. Tissue-specific isoform functions (25 splice variants reported) .

Product Specs

Introduction
The CCR4-NOT Transcription Complex, Subunit 8 (CNOT8) is a member of the CAF1 family. As a ubiquitous transcription factor, CNOT8 is essential for various processes and functions within the CCR-NOT complex. This complex, responsible for general transcription regulation, interacts with BTG2 and comprises CHAF1A, CHAF1B, CNOT1, CNOT2, CNOT3, CNOT4, CNOT6, and CNOT8.
Description
Recombinant human CNOT8, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 315 amino acids (residues 1-292) with a molecular weight of 35.9 kDa. It features a 23 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic methods.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The CNOT8 solution is supplied at a concentration of 0.25 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 0.15 M NaCl, 10% glycerol, and 1 mM DTT.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to freeze the product at -20°C. To ensure long-term stability, adding a carrier protein like HSA or BSA (0.1%) is advised. Repeated freezing and thawing should be avoided.
Purity
The purity of CNOT8 is greater than 85.0% as determined by SDS-PAGE analysis.
Synonyms
CCR4-NOT transcription complex subunit 8, CAF1, CALIF, hCAF1, POP2, CAF1-like protein, CAF2, CCR4-associated factor 8, Caf1b, CNOT8.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMPAALVE NSQVICEVWA SNLEEEMRKI REIVLSYSYI AMDTEFPGVV VRPIGEFRSS IDYQYQLLRC NVDLLKIIQL GLTFTNEKGE YPSGINTWQF NFKFNLTEDM YSQDSIDLLA NSGLQFQKHE EEGIDTLHFA ELLMTSGVVL CDNVKWLSFH SGYDFGYMVK LLTDSRLPEE EHEFFHILNL FFPSIYDVKY LMKSCKNLKG GLQEVADQLD LQRIGRQHQA GSDSLLTGMA FFRMKELFFE DSIDDAKYCG RLYGLGTGVA QKQNEDVDSA QEKMSILAII NNMQQ.

Q&A

What is CNOT8 and what is its primary function in human cells?

CNOT8 is a protein encoded by the CNOT8 gene located on human chromosome 5. It functions as a deadenylase subunit of the CCR4-Not complex, which plays a crucial role in mRNA deadenylation and subsequent decay . The protein possesses DEDD domain with approximately 81% amino acid identity to its ortholog CNOT7, suggesting potential functional redundancy in certain cellular contexts . CNOT8's primary function involves shortening the poly(A) tail of target mRNAs, thereby initiating their degradation pathway and regulating gene expression post-transcriptionally .

How does CNOT8 differ from other deadenylase subunits in the CCR4-Not complex?

The CCR4-Not complex contains four deadenylase orthologs that can be categorized into two groups: Ccr4 orthologs (CNOT6 and CNOT6L) and Caf1 orthologs (CNOT7 and CNOT8) . While CNOT7 and CNOT8 share high sequence similarity in their DEDD domains (approximately 81% identity), they may have both overlapping and distinct functions depending on the cellular context . Unlike CNOT6/CNOT6L which interact transiently with the complex, CNOT8 forms more stable associations with core components like CNOT1 and CNOT3 . Methodologically, distinguishing CNOT8's specific role requires either generating double knockouts with CNOT7 to overcome potential compensatory mechanisms or performing RNA-immunoprecipitation experiments to identify unique mRNA targets.

What are the known protein interactions of CNOT8 and their functional significance?

CNOT8 has been shown to interact with multiple proteins including:

Interacting ProteinFunctionExperimental Evidence
BTG1, BTG2Antiproliferative proteinsCo-immunoprecipitation
CNOT1Scaffolding subunit of CCR4-NotStructural studies, Co-IP
CNOT3Core component of CCR4-NotCo-immunoprecipitation
Tob1Regulator of mRNA decayBinding assays
Pabpc1Poly(A) binding proteinRNA-protein complexes

These interactions are functionally significant as they facilitate CNOT8's role in mRNA deadenylation. For instance, BTG1/BTG2 interactions may recruit CNOT8 to specific mRNAs, while CNOT1/CNOT3 interactions position CNOT8 correctly within the CCR4-Not complex . The interaction with Tob1 and Pabpc1 appears critical for target mRNA clearance through its deadenylase activity as demonstrated by rescue experiments .

How does CNOT8 contribute to the DNA damage response pathway?

CNOT8 plays an essential role in cellular response to DNA damage, particularly after ionizing radiation (IR). When CNOT8 is depleted in cells exposed to IR, several key observations have been documented:

  • Altered phosphorylation patterns of DNA damage response (DDR) proteins, including Chk1 (at Ser345), H2AX (at Ser139), and RPA (at Ser4/8)

  • Significant increase in irradiation-induced foci formation of γH2AX, RPA, 53BP1, and RAD51

  • Enhanced cellular sensitivity to DNA damage

Methodologically, these effects can be studied using siRNA-mediated knockdown of CNOT8 followed by exposure to ionizing radiation (typically 3 Gy) and subsequent analysis of DDR protein phosphorylation by Western blotting and immunofluorescence microscopy to quantify nuclear foci formation .

What experimental approaches can be used to investigate CNOT8's role in DNA repair mechanisms?

Researchers investigating CNOT8's involvement in DNA repair mechanisms should consider these methodological approaches:

  • siRNA-mediated knockdown: Transfect cells with CNOT8-specific siRNAs (0.5 nM) using Oligofectamine in Opti-MEM medium with 5-6 hour incubation

  • Cell viability assessment: Measure ATP levels using Cell Titer-Glo Luminescence reagent over multiple time points (24h, 48h, 72h, 96h) post-transfection

  • DNA damage induction: Expose control and CNOT8-depleted cells to 3 Gy ionizing radiation

  • Western blot analysis: Assess phosphorylation status of key DDR proteins (Chk1, H2AX, RPA, NBS1, KAP1) at various time points (1, 2, 4, 8, 24h) post-irradiation

  • Immunofluorescence microscopy: Quantify DNA damage repair foci using antibodies against RPA, γH2AX, 53BP1, and RAD51 at key timepoints (8h and 24h) post-irradiation

  • Rescue experiments: Reintroduce wild-type or catalytically inactive CNOT8 to determine if deadenylase activity is required for DNA repair functions

Research shows that CNOT8-depleted cells exhibit hypersensitivity to DNA damage, with significantly increased foci formation of RPA, γH2AX, 53BP1, and RAD51 compared to control cells, particularly at 8 hours post-irradiation .

How does CNOT8 depletion affect the formation of DNA damage repair foci?

CNOT8 depletion leads to significant alterations in DNA damage repair foci formation following ionizing radiation exposure:

Repair ProteinEffect in CNOT8-depleted cellsStatistical Significance
RPA fociSignificantly increased at 8h and 24hp=0.003 (8h), p=0.011 (24h)
γH2AX fociPeak value at 8h, significantly higher than controlsp=0.001 (8h), p=0.065 (24h)
53BP1 fociSignificantly higher at 8h, disappeared by 24hp=0.016 (8h), p=0.220 (24h)
RAD51 fociSignificantly higher at both 8h and 24hp=0.021 (8h), p=0.009 (24h)

This pattern suggests that CNOT8 depletion leads to cellular hypersensitivity to ionizing radiation, potentially by affecting the homologous recombination (HR) repair pathway. The significantly higher RAD51 foci formation in CNOT8-depleted cells indicates enhanced HR repair activity, which may be a compensatory response to defective DNA damage repair mechanisms . Experimentally, this can be investigated using immunofluorescence microscopy with highly specific antibodies against these repair proteins at different time points after irradiation.

What is the role of CNOT8 in embryonic development?

CNOT8 plays a critical role in early embryonic development, evidenced by the fact that CNOT8 knockout results in early embryonic lethality in mice . While CNOT8 knockout embryonic stem cells (ESCs) can be established, they exhibit significant differentiation defects, particularly during the transition from naïve to formative pluripotency states .

The mechanism underlying this developmental importance involves CNOT8's function in eliminating naïve regulation networks through mRNA clearance. Specifically, CNOT8 facilitates the deadenylation and degradation of mRNAs encoding proteins involved in maintaining the naïve pluripotent state. In its absence, these mRNAs persist with longer poly(A) tails and extended half-lives, leading to the inappropriate maintenance of naïve pluripotency factors during differentiation .

How does CNOT8 regulate the transition from naïve to formative pluripotency?

CNOT8 regulates the naïve-to-formative pluripotency transition through targeted mRNA degradation of naïve pluripotency genes. In CNOT8 knockout ESCs, several hundred naïve-like genes remain highly expressed during attempted differentiation into the formative state . These persistent genes are particularly enriched in:

  • Lipid metabolic processes

  • Gene expression regulation

  • Core pluripotency networks

Together, these inappropriately maintained genes form what can be termed "naïve regulation networks" that prevent proper differentiation . Experimentally, knockdown of selected genes from these naïve regulation networks partially rescues the differentiation defects of CNOT8 knockout ESCs, confirming that CNOT8's primary role in this transition is to eliminate these naïve pluripotency-maintaining factors .

The molecular mechanism involves CNOT8's deadenylase activity, which shortens the poly(A) tails of target mRNAs, reducing their stability and expression levels. This process requires CNOT8's interaction with the CCR4-Not complex and its association with Tob1 and Pabpc1 proteins .

What experimental approaches can be used to study CNOT8's function in pluripotency?

Researchers investigating CNOT8's role in pluripotency should consider these methodological approaches:

  • Genetic manipulation: Generate CNOT8 knockout ESCs using CRISPR-Cas9 or conditional knockout systems to circumvent embryonic lethality

  • Differentiation protocols: Compare differentiation capacity of wild-type versus CNOT8-deficient ESCs using established protocols for inducing formative pluripotency

  • Transcriptome analysis: Perform RNA-seq to identify differentially expressed genes during differentiation, with particular focus on naïve pluripotency factors

  • mRNA stability assays: Measure mRNA half-lives and poly(A) tail lengths in control versus CNOT8-deficient cells to identify direct targets

  • Rescue experiments:

    • Reintroduce wild-type or catalytically inactive CNOT8 to determine if deadenylase activity is required

    • Knockdown specific naïve pluripotency factors in CNOT8-deficient cells to test for rescue of differentiation defects

  • Protein-RNA interaction studies: Perform RNA-immunoprecipitation to identify direct mRNA targets of CNOT8

Notably, research shows that knockdown of selected naïve regulation network genes can partially rescue differentiation defects in CNOT8 knockout ESCs, confirming the causal relationship between persistent expression of these factors and the observed phenotype .

How does CNOT8 contribute to mRNA deadenylation and decay?

CNOT8 functions as a catalytic subunit of the CCR4-Not complex, possessing intrinsic deadenylase activity that removes the poly(A) tail from target mRNAs . This deadenylation is typically the rate-limiting step in mRNA decay, as it precedes either decapping and 5'-to-3' degradation or 3'-to-5' degradation by the exosome.

The molecular mechanism involves:

  • Recognition of target mRNAs through interactions with RNA-binding proteins (RBPs) or microRNA-induced silencing complexes

  • Recruitment of the CCR4-Not complex through CNOT8's interactions with core components CNOT1 and CNOT3

  • Physical interaction with Tob1 and Pabpc1 proteins to facilitate target access

  • Enzymatic removal of adenosine residues from the poly(A) tail via CNOT8's DEDD domain

  • Destabilization of the mRNA, leading to its degradation by cellular exonucleases

Experimental evidence confirms that CNOT8 depletion leads to deadenylation defects of its targets, resulting in increased poly(A) tail lengths and extended mRNA half-lives, ultimately elevating their expression levels .

What is the relationship between CNOT8 and other CCR4-Not complex components?

CNOT8 interacts with multiple components of the CCR4-Not complex, forming a functional deadenylase module:

CCR4-Not ComponentRelationship with CNOT8Functional Significance
CNOT1Direct interaction Scaffolding protein that positions CNOT8 within the complex
CNOT3Direct interaction Core component that may influence target specificity
CNOT6/CNOT6LTransient interaction Alternative deadenylase subunits that may function in different contexts
CNOT7Paralog with ~81% identity in DEDD domain Potentially redundant function in some contexts

These interactions are critical for CNOT8's function, as the CCR4-Not complex operates as an integrated unit rather than as isolated subunits. The scaffolding protein CNOT1 is particularly important, as it positions CNOT8 correctly within the complex architecture .

While CNOT7 and CNOT8 share high sequence similarity and may have overlapping functions, research suggests they also have distinct roles. For instance, while CNOT8 knockout results in early embryonic lethality, CNOT8 knockout ESCs can be established , indicating complex compensatory mechanisms that may depend on cellular context.

What are the regulatory mechanisms that control CNOT8 activity?

While the search results don't provide comprehensive information on the regulatory mechanisms controlling CNOT8 activity, several potential regulatory pathways can be inferred:

  • Protein-protein interactions: Interactions with BTG1/BTG2, Tob1, and Pabpc1 likely modulate CNOT8's activity by influencing target recognition or catalytic efficiency

  • Complex assembly regulation: As CNOT8 functions within the CCR4-Not complex, factors affecting complex assembly or stability would impact CNOT8 activity

  • Post-translational modifications: Although not specifically mentioned in the search results, deadenylase activity is often regulated by phosphorylation or other modifications

  • Target specificity mechanisms: CNOT8 appears to preferentially target mRNAs involved in naïve pluripotency and other specific cellular functions , suggesting mechanisms for selective target recognition

To study these regulatory mechanisms, researchers should consider:

  • Protein-protein interaction studies using co-immunoprecipitation and mass spectrometry

  • Phospho-proteomics to identify potential regulatory phosphorylation sites

  • In vitro deadenylation assays with potential regulatory factors

  • Structure-function analyses to identify regulatory domains within CNOT8

What are the most effective techniques for studying CNOT8 function in cellular models?

Based on the research literature, several effective techniques for studying CNOT8 function include:

  • Genetic manipulation approaches:

    • siRNA transfection using 0.5 nM CNOT8-specific siRNAs with Oligofectamine in Opti-MEM medium (5-6 hour incubation)

    • CRISPR-Cas9 knockout systems for complete elimination of CNOT8

    • Inducible expression systems for controlled reintroduction of wild-type or mutant CNOT8

  • Functional assays:

    • Cell viability assessment using Cell Titer-Glo Luminescence reagent to measure ATP levels

    • Differentiation assays for pluripotent stem cells to evaluate developmental functions

    • DNA damage response assessment following ionizing radiation (3 Gy recommended)

  • Molecular analyses:

    • Western blotting to detect protein levels and phosphorylation states of DDR proteins

    • Immunofluorescence microscopy to quantify nuclear foci formation of repair proteins

    • RNA-seq to identify differentially expressed genes in CNOT8-deficient cells

    • Poly(A) tail length analysis to assess deadenylation activity

    • mRNA half-life measurements to determine effect on transcript stability

  • Protein-protein interaction studies:

    • Co-immunoprecipitation to identify interacting partners

    • Proximity labeling approaches to map the CNOT8 interactome

Each technique should be selected based on the specific aspect of CNOT8 function being investigated.

How can researchers effectively measure CNOT8's deadenylase activity?

To effectively measure CNOT8's deadenylase activity, researchers should consider these methodological approaches:

  • In vitro deadenylase assays:

    • Express and purify recombinant CNOT8 protein

    • Synthesize radiolabeled or fluorescently-labeled RNA substrates with defined poly(A) tail lengths

    • Incubate CNOT8 with RNA substrates under appropriate buffer conditions

    • Analyze deadenylation by denaturing gel electrophoresis to visualize poly(A) tail shortening

  • Cellular deadenylation assays:

    • Global poly(A) tail length analysis using TAIL-seq or similar techniques in control versus CNOT8-depleted cells

    • Gene-specific poly(A) tail length analysis using LM-PAT (Ligation-Mediated Poly(A) Test) or ePAT (extension PAT) assays

    • Transcriptional pulse-chase experiments with metabolic labeling to track deadenylation kinetics

  • mRNA stability measurements:

    • Transcription inhibition with actinomycin D followed by qRT-PCR at multiple time points to calculate mRNA half-lives

    • Metabolic labeling of newly synthesized RNA to track decay rates

  • Rescue experiments:

    • Catalytically inactive CNOT8 mutants (mutations in the DEDD domain) can be used in rescue experiments to determine if deadenylase activity is required for observed phenotypes

Research shows that CNOT8 depletion leads to increased poly(A) tail lengths and extended half-lives of target mRNAs, confirming its role in deadenylation .

What are the challenges in studying CNOT8's specific roles compared to other deadenylases?

Researchers face several significant challenges when attempting to distinguish CNOT8's specific roles from other deadenylases:

  • Functional redundancy with CNOT7:

    • CNOT7 and CNOT8 share approximately 81% amino acid identity in their catalytic DEDD domains

    • Both proteins exhibit similar deadenylation activity in vitro and may function in the same pathways

    • Compensatory mechanisms may mask phenotypes in single knockout studies

  • Complex formation complications:

    • CNOT8 functions within the larger CCR4-Not complex, making it difficult to attribute observed effects solely to CNOT8

    • The complex contains multiple deadenylase subunits (CNOT6, CNOT6L, CNOT7, CNOT8) with potentially overlapping functions

  • Methodological challenges:

    • Generating effective antibodies that distinguish between the highly similar CNOT7 and CNOT8 proteins

    • Designing specific inhibitors for mechanistic studies

    • Creating appropriate controls for functional assays

  • Context-dependent functions:

    • CNOT8's role may vary significantly between cell types and developmental stages

    • Different experimental conditions may lead to contradictory results

To overcome these challenges, researchers should consider:

  • Double knockout studies (CNOT7/CNOT8) followed by selective rescue experiments

  • Chimeric protein approaches to identify domain-specific functions

  • Cell type-specific conditional knockout systems

  • High-throughput screens to identify specific CNOT8 substrates

  • Structural biology approaches to identify unique features for targeted studies

What is known about CNOT8's potential role in human diseases?

While the search results don't provide comprehensive information about CNOT8's direct involvement in human diseases, several connections can be inferred based on its molecular functions:

  • DNA damage response and cancer: CNOT8 plays a role in the cellular response to DNA damage, with CNOT8-depleted cells showing hypersensitivity to ionizing radiation . This suggests potential involvement in cancer development or response to radiotherapy.

  • Developmental disorders: Given that CNOT8 knockout is embryonically lethal in mice and plays a crucial role in the naïve-to-formative pluripotency transition , mutations affecting CNOT8 function could potentially contribute to developmental disorders.

  • Relation to CCR4-Not complex diseases: The search results indicate that mutations in other CCR4-Not complex components are associated with various human diseases:

    • CNOT1 mutations: Syndrome of pancreatic agenesis and holoprosencephaly (HPE)

    • CNOT3 mutations: T-cell acute lymphoblastic leukemia (T-ALL) and ventricular tachyarrhythmias

By association, CNOT8 dysfunction might contribute to similar conditions, though direct evidence is not provided in the search results.

Researchers investigating CNOT8's disease relevance should consider genetic association studies, analysis of expression levels in patient samples, and functional studies of disease-associated variants.

How might targeting CNOT8 be relevant for therapeutic development?

Based on its cellular functions, targeting CNOT8 could have therapeutic relevance in several contexts:

  • Cancer therapy: CNOT8's role in the DNA damage response suggests potential for cancer therapeutic development:

    • CNOT8 inhibition could sensitize cancer cells to radiotherapy or DNA-damaging chemotherapeutics

    • The study directly states that CNOT8 "can be identified as a target of cancer therapeutic agents"

    • CNOT8-deficient cells show increased sensitivity to DNA damage, suggesting synthetic lethality approaches could be developed

  • Regenerative medicine: CNOT8's role in regulating pluripotency transitions suggests potential applications in stem cell-based therapies:

    • Temporary inhibition might enhance maintenance of pluripotent cells

    • Controlled modulation could potentially direct differentiation toward specific lineages

  • RNA-based therapeutics: As a regulator of mRNA stability, CNOT8 modulation could potentially be used to stabilize therapeutic mRNAs or destabilize disease-associated transcripts

Methodological approaches for therapeutic development might include:

  • Small molecule inhibitor screening targeting CNOT8's deadenylase activity

  • Peptide-based disruption of specific protein-protein interactions

  • RNA interference approaches for temporary suppression

  • Targeted protein degradation strategies (PROTACs)

What are the implications of CNOT8 research for understanding fundamental biological processes?

CNOT8 research has significant implications for understanding several fundamental biological processes:

  • Post-transcriptional gene regulation:

    • CNOT8 exemplifies how mRNA decay is a critical regulatory layer in gene expression control

    • Its function demonstrates how targeted mRNA degradation can shape cellular transitions and responses

    • The deadenylation process it catalyzes is often rate-limiting in mRNA decay pathways

  • Cellular pluripotency and differentiation:

    • CNOT8's role in clearing naïve pluripotency factors highlights the importance of active elimination of previous gene expression programs during cell state transitions

    • This mechanism represents a fundamental principle: development requires not only activation of new genes but also active suppression of previous states

  • DNA damage response coordination:

    • CNOT8's involvement in DDR reveals connections between RNA processing and genome integrity maintenance

    • The increased formation of repair foci in CNOT8-depleted cells suggests regulation of repair pathway choice or efficiency

  • Redundancy and specialization in biological systems:

    • The relationship between CNOT7 and CNOT8 (paralogs with ~81% identity) provides insights into how gene duplication events lead to both redundancy and specialization

    • The ability to establish CNOT8 knockout ESCs despite embryonic lethality of CNOT8 knockout mice highlights context-dependent requirements and compensatory mechanisms

These fundamental insights extend beyond CNOT8 itself, providing principles that may apply broadly across biological systems and processes.

Product Science Overview

Structure and Composition

The CCR4-NOT complex is composed of several subunits, each contributing to its diverse functions. The core components of the complex include:

  • CNOT1: Acts as a scaffold, bringing together other subunits and effector proteins .
  • CNOT2 and CNOT3: Structural components linked to the maintenance of embryonic stem cells .
  • CNOT4: Functions as an E3 ubiquitin ligase .
  • CNOT6 and CNOT6L: 3′-5′ exonucleases with a preference for polyadenylated mRNA substrates .
  • CNOT7 and CNOT8: 3′-5′ exonucleases that are partially redundant .
  • CNOT9, CNOT10, and CNOT11: Non-catalytic subunits that form specific modules .
Subunit 8 (CNOT8)

CNOT8, also known as CCR4-NOT Transcription Complex, Subunit 8, is one of the 3′-5′ exonucleases within the complex. It plays a significant role in mRNA decay by shortening the poly(A) tail at the 3’ end of eukaryotic mRNAs . This activity is crucial for the regulation of mRNA stability and, consequently, gene expression.

Functions and Mechanisms

The CCR4-NOT complex is involved in multiple regulatory processes:

  1. mRNA Degradation: The complex shortens the poly(A) tail of mRNAs, leading to their degradation .
  2. Transcription Regulation: It regulates transcription initiation and elongation, impacting gene expression at the transcriptional level .
  3. Ubiquitination: The E3 ubiquitin ligase activity of CNOT4 within the complex tags proteins for degradation .
  4. Protein Modification: The complex is involved in various protein modification processes, influencing protein function and stability .
Biological Significance

The CCR4-NOT complex is essential for maintaining cellular homeostasis and responding to environmental changes. Its role in mRNA metabolism ensures that gene expression is tightly regulated, allowing cells to adapt to dynamic conditions. The complex’s involvement in protein quality control and mRNA decay highlights its importance in cellular function and health .

In summary, the CCR4-NOT transcription complex, particularly Subunit 8 (CNOT8), is a vital component of the cellular machinery that regulates gene expression through various mechanisms. Its multifunctional nature and evolutionary conservation underscore its significance in eukaryotic biology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.